Skip to main content
SpringerLink
Log in

Apolipoprotein profile in type II diabetic patients with and without coronary heart disease

  • Original Contributions
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

Diabetes mellitus is frequently associated with lipid metabolism abnormalities. In the present study the lipid and apolipoprotein profiles have been compared in type II diabetic subjects with (n=30) and without (n=30) coronary heart disease (CHD). All subjects were studied after good metabolic control had been achieved. Significant differences in plasrna lipids and apolipoproteins were seen in diabetic patients with CHD in comparison with diabetics without CHD. Patients with CHD presented higher total cholesterol, triglyceride, LDL-cholesterol, apo B, apo CII and apo CIII levels and total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol ratios and lower HDL-cholesterol values and apo AI/o B ratio than the patients without CHD. The same findings were found in females; while male subjects with CHD had significantly increased total cholesterol, LDL-cholesterol and apo B levels and total cholesterol/HDL-cholesterol and LDL/cholesterol/HDL-cholesterol ratios and significantly decreased apo AI/o B ratio compared with males without CHD. These findings support the concept that the apolipoprotein profile plays a remarkable role as risk factor for CHD in type II diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Averna M. R., Barbagallo C. M., Galione A., Carroccio A., Labisi M., Marino G., Montalto G., Notarbartolo A.: Serum apolipoprotein profile of hypertriglyceridemic patients with chronic renal failure: a comparison with type IV hyperlipoproteinemia — Metabolism38, 601–602, 1989.

    Article  PubMed  CAS  Google Scholar 

  2. Averna M. R., Carroccio A., Barbagallo C. M., Montalto G., Soresi M., Notarbartolo A.: Diagnostic use of fructosamine assay in the control of type II diabetes mellitus — Acta diabetol. lat.25, 63–68, 1988.

    Article  PubMed  CAS  Google Scholar 

  3. Baker J. R., Johnson R., Scott D. J.: Serum fructosamine concentration in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management — Brit. med. J.228, 863–867, 1984.

    Google Scholar 

  4. Barrett-Connor E., Philippi T., Khaw K. T.: Lipoproteins as predictor of ischemic heart disease in non-insulin-dependent diabetic men — Amer. J. prev. Med.3, 206–210, 1987.

    CAS  Google Scholar 

  5. Becker W., Schäfer W., Ziegenbein W.: Standardization of immunochemical quantitation of human apolipoprotein A and B — La Ricerca Clin. Lab.10, 203–212, 1980.

    CAS  Google Scholar 

  6. Bittolo Bon G., Cazzolato G., Avogaro P.: Lipids, lipoproteins and apolipoproteins in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus — Acta diabetol. lat.21, 315–324, 1984.

    Article  PubMed  CAS  Google Scholar 

  7. Carvalho A. C. A., Colman R. V., Lees R. S.: Platelet function in hyperlipoproteinemia — New Engl. J. Med.290, 434–435, 1974.

    Article  PubMed  CAS  Google Scholar 

  8. Crepaldi G., Manzato E.: Atherogenic factors in diabetes: the role of lipoproteins metabolism — Postgrad. Med. J.64 (Suppl. 3), 10–12, 1988.

    PubMed  CAS  Google Scholar 

  9. Daví G., Averna M. R., Catalano I., Barbagallo C. M., Giovenco E., Carroccio A., Notarbartolo A., Strano A.: Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control — Diabet. Res.10, 7–12, 1989.

    Google Scholar 

  10. Faber O. K., Binder C.: C-peptide response to glucagon: a test for the residual β-cell function in diabetes mellitus — Diabetes26, 605–610, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Friedewald W. T., Levy R. J., Frederickson D. S.: Estimation of the concentration of low-density lipoproteins cholesterol in plasma, without use of the preparative ultracentrifuge — Clin. Chem.18, 499–502, 1980.

    Google Scholar 

  12. Garcia M. J., McNamara P. M., Gordon T., Kannel W. B.: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study — Diabetes23, 105–111, 1974.

    PubMed  CAS  Google Scholar 

  13. Hjelm M., de Verdier C. H.: A methodological study of the enzymatic determination of glucose in blood — Scand. J. clin. Lab. Invest.15, 415–428, 1963.

    PubMed  CAS  Google Scholar 

  14. Laasko M., Pyroala K.: Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease — Atherosclerosis74, 55–63, 1988.

    Article  Google Scholar 

  15. Laasko M., Pyroala K., Sarlund H., Vountilanen E.: Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus — Arteriosclerosis6, 679–684, 1986.

    Google Scholar 

  16. Laasko M., Vountilainen E., Pyroala K., Sarlund H.: Association of low HDL and HDL2 cholesterol with coronary heart disease in non-insulin-dependent diabetics — Arteriosclerosis5, 653–658, 1986.

    Google Scholar 

  17. Lisch H. J., Sailer S.: Lipoprotein patterns in diet, sulphonylurea and insulin treated diabetics — Diabetologia20, 118–122, 1981.

    Article  PubMed  CAS  Google Scholar 

  18. Lopez-Virella M. F., Stone J., Ellis S., Goldwell J. A.: Cholesterol determination in high density lipoproteins separated by three different methods — Clin. Chem.23, 882–884, 1977.

    Google Scholar 

  19. Mancini G., Carbonara A. O., Heremans J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion — Immunochemistry2, 235–254, 1965.

    Article  PubMed  CAS  Google Scholar 

  20. Mosca A., Carenini A., Samaja M., Saibene V.: Improvement of glycosylated hemoglobin measurement by disposable ion-exchange columns — La Ricerca Clin. Lab.10, 251–253, 1980.

    Article  CAS  Google Scholar 

  21. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance — Diabetes28, 1039–1057, 1979.

    Google Scholar 

  22. Nikkilä E. A.: Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes mellitus? — Acta endocrinol. (Kbh)110 (Suppl. 272), 27–30, 1985.

    Google Scholar 

  23. Pontiroli A. E., Calderara A., Bonisolli L., Maffi P., De Pasqua A., Margonato A., Radaelli G., Gallus G., Pozza G.: Genetic and metabolic risk factors for the development of the late complications in type I (insulin-dependent) diabetes — Acta diabetol. lat.23, 351–366, 1986.

    Article  PubMed  CAS  Google Scholar 

  24. Ronnemaa T., Laasko M., Kallio V., Pyroala K., Marniemi J., Puukka P.: Serum lipids, lipoproteins and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients — Amer. J. Epidemiol.130, 632–645, 1989.

    CAS  Google Scholar 

  25. Roschlau P., Bernt E., Gruber W.: Enzymatische Bestimmung der Gesamte-Cholesterins in Serum — Chem. klin. Biochem.12, 226–227, 1974.

    Google Scholar 

  26. Schauer U. J. W., Pissarek D., Panzram G.: Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study — Acta diabetol. lat.26, 35–42, 1989.

    Article  PubMed  CAS  Google Scholar 

  27. Taskinen M. R., Kuuśi T., Nikkilä E. A.: Serum lipoproteins and atherosclerosis in type 1 and type 2 diabetes. In:Andreani D., Crepaldi G., Di Mario U., Pozza G. (Eds): Diabetic Complications: Early Diagnosis and Treatment. John Wiley & Sons Ltd., Chichester, 1987; pp. 25–35.

    Google Scholar 

  28. Wahalefeld A. H.: Triglyceride determination after enzymatic hydrolysis. In:Bergmeyer H. U. (Ed.): Methods of Enzymatic Analysis. vol. 4. Academic Press, 1974; pp. 1831–1835.

Download references

Author information

Authors and Affiliations

  1. Istituto di Medicina Interna e Geriatria, Cattedra di Patologia Medica, Università di Palermo, Palermo

    Carlo M. Barbagallo, Maurizio R. Averna, Salvatore Amato, Giuseppina Marino, Mirella Labisi, Angela Camemi Rao, Gian Franco Cupidi & Alberto Notarbartolo

  2. Cattedra di Patologia Medica II, Università di Roma, Roma, Italy

    Mario Barbagallo

Authors
  1. Carlo M. Barbagallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maurizio R. Averna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salvatore Amato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppina Marino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mirella Labisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Angela Camemi Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mario Barbagallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gian Franco Cupidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Alberto Notarbartolo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barbagallo, C.M., Averna, M.R., Amato, S. et al. Apolipoprotein profile in type II diabetic patients with and without coronary heart disease. Acta diabet. lat 27, 371–377 (1990). https://doi.org/10.1007/BF02580943

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02580943

Key-words

Search

Navigation